Globus Medical Company Insiders
GMED Stock | USD 82.94 0.05 0.06% |
Globus Medical's insiders are aggressively selling. The analysis of insiders' sentiment of trading Globus Medical stock suggests that all insiders are panicking at this time. Globus Medical employs about 5 K people. The company is managed by 19 executives with a total tenure of roughly 94 years, averaging almost 4.0 years of service per executive, having 263.16 employees per reported executive.
David Paul Chairman Co-Founder, Chairman, CEO, Chairman of Compensation Committee and Chairman of Nominating and Corporate Governance Committee |
Brett Murphy President Group President of Commercial Operations |
Globus Medical's Insider Buying Vs Selling
0
Selling | Buying |
Latest Trades
2024-12-02 | Kelly Huller | Disposed 2500 @ 87 | View | ||
2024-11-06 | Kelly Huller | Disposed 5000 @ 81.01 | View | ||
2024-10-16 | David D Davidar | Disposed 30000 @ 75.04 | View | ||
2024-09-13 | Ann D Rhoads | Disposed 15000 @ 70.36 | View | ||
2024-07-11 | Leslie V Norwalk | Disposed 1000 @ 70 | View | ||
2024-05-10 | Dan Lemaitre | Disposed 63300 @ 64.61 | View | ||
2024-05-08 | David D Davidar | Disposed 20000 @ 65 | View | ||
2024-03-15 | Leslie V Norwalk | Disposed 10590 @ 51.99 | View |
Monitoring Globus Medical's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Globus |
Globus Medical's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Globus Medical's future performance. Based on our forecasts, it is anticipated that Globus will maintain a workforce of about 5000 employees by January 2025.Globus Medical Management Team Effectiveness
The company has return on total asset (ROA) of 0.0473 % which means that it generated a profit of $0.0473 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0222 %, meaning that it created $0.0222 on every $100 dollars invested by stockholders. Globus Medical's management efficiency ratios could be used to measure how well Globus Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of December 11, 2024, Return On Tangible Assets is expected to decline to 0.04. In addition to that, Return On Capital Employed is expected to decline to 0.03. At present, Globus Medical's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 82.5 M, whereas Return On Tangible Assets are forecasted to decline to 0.04.As of December 11, 2024, Common Stock Shares Outstanding is expected to decline to about 104.1 M. In addition to that, Net Income Applicable To Common Shares is expected to decline to about 120.8 M
Globus Medical Workforce Comparison
Globus Medical is rated # 3 in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 49,274. Globus Medical retains roughly 5,000 in number of employees claiming about 10% of equities under Health Care industry.
Globus Medical Profit Margins
The company has Profit Margin (PM) of 0.04 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.18 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.18.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.85 | 0.6505 |
|
| |||||
Net Profit Margin | 0.0744 | 0.0783 |
|
| |||||
Operating Profit Margin | 0.0806 | 0.0849 |
|
| |||||
Pretax Profit Margin | 0.1 | 0.1054 |
|
| |||||
Return On Assets | 0.023 | 0.0242 |
|
| |||||
Return On Equity | 0.0292 | 0.0307 |
|
|
Globus Medical Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Globus Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Globus Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Globus Medical insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-12-01 | 0.5455 | 12 | 22 | 305,417 | 494,792 |
2024-09-01 | 0.5 | 3 | 6 | 60,000 | 101,000 |
2024-06-01 | 0.6 | 3 | 5 | 52,500 | 135,800 |
2024-03-01 | 2.8 | 14 | 5 | 457,500 | 33,590 |
2023-12-01 | 4.0 | 4 | 1 | 191,100 | 342,200 |
2023-06-01 | 0.8 | 4 | 5 | 43,450 | 86,900 |
2023-03-01 | 2.5 | 15 | 6 | 382,467 | 76,634 |
2022-12-01 | 0.5 | 1 | 2 | 7,500 | 15,000 |
2022-06-01 | 1.0 | 2 | 2 | 62,500 | 34,000 |
2022-03-01 | 1.5 | 15 | 10 | 448,334 | 61,694 |
2021-09-01 | 0.4375 | 7 | 16 | 104,166 | 210,332 |
2021-06-01 | 0.6667 | 10 | 15 | 323,022 | 646,044 |
2021-03-01 | 4.3333 | 13 | 3 | 515,768 | 46,152 |
2020-12-01 | 0.6154 | 8 | 13 | 70,220 | 331,295 |
2020-09-01 | 0.6471 | 11 | 17 | 696,305 | 1,060,000 |
2020-06-01 | 0.8 | 4 | 5 | 109,776 | 218,152 |
2019-12-01 | 0.2857 | 2 | 7 | 28,076 | 63,536 |
2019-09-01 | 0.5 | 2 | 4 | 90,000 | 103,000 |
2019-06-01 | 1.0 | 1 | 1 | 25,000 | 0.00 |
2019-03-01 | 0.7097 | 22 | 31 | 816,582 | 622,316 |
2018-09-01 | 0.5 | 4 | 8 | 1,151,812 | 2,011,818 |
2018-06-01 | 0.65 | 26 | 40 | 793,383 | 1,545,124 |
2018-03-01 | 2.4286 | 17 | 7 | 741,500 | 172,000 |
2017-12-01 | 0.5 | 5 | 10 | 73,459 | 175,996 |
2017-09-01 | 1.0 | 1 | 1 | 300,000 | 15,000 |
2017-06-01 | 0.5 | 1 | 2 | 16,153 | 32,306 |
2017-03-01 | 6.0 | 12 | 2 | 627,500 | 115,000 |
2016-09-01 | 0.5 | 2 | 4 | 107,692 | 215,384 |
2016-03-01 | 2.5 | 15 | 6 | 585,600 | 60,645 |
2015-09-01 | 1.5 | 3 | 2 | 215,000 | 20,000 |
2015-06-01 | 0.25 | 1 | 4 | 3,076 | 206,152 |
2015-03-01 | 1.25 | 10 | 8 | 532,500 | 2,115,663 |
2014-06-01 | 0.8 | 4 | 5 | 6,068,500 | 6,098,500 |
2014-03-01 | 1.0625 | 17 | 16 | 1,323,829 | 2,589,471 |
2013-09-01 | 0.1538 | 2 | 13 | 102,478 | 21,814,035 |
2013-06-01 | 0.5556 | 5 | 9 | 2,884,530 | 3,114,530 |
2013-03-01 | 3.3333 | 10 | 3 | 196,000 | 71,103 |
2012-12-01 | 1.0 | 1 | 1 | 435,350 | 870,700 |
2012-09-01 | 0.766 | 36 | 47 | 42,672,634 | 91,741,044 |
Globus Medical Notable Stakeholders
A Globus Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Globus Medical often face trade-offs trying to please all of them. Globus Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Globus Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
David Paul | Co-Founder, Chairman, CEO, Chairman of Compensation Committee and Chairman of Nominating and Corporate Governance Committee | Profile | |
Brett Murphy | Group President of Commercial Operations | Profile | |
Keith Pfeil | Chief Financial Officer, Senior Vice President | Profile | |
David Demski | Group President of Emerging Technologies, Director and Member of Nominating and Corporate Governance Committee | Profile | |
Daniel Scavilla | Executive Vice President, Chief Commercial Officer and President - Trauma | Profile | |
Steve Zarrilli | Independent Director | Profile | |
Ann Rhoads | Independent Director | Profile | |
James Tobin | Independent Director | Profile | |
Daniel Lemaitre | Independent Director | Profile | |
David Davidar | Co-Founder, Sr. VP of Operations and Director | Profile | |
Kelly Esq | General VP | Profile | |
Mike Reeder | Ex Officer | Profile | |
Robert Douglas | Independent Director | Profile | |
Steven Payne | VP Controller | Profile | |
Kelly Huller | Senior Vice President General Counsel, Corporate Secretary | Profile | |
Stephen Zarrilli | Independent Director | Profile | |
Brian Kearns | Senior Relations | Profile | |
Richard Holifield | Ex Officer | Profile | |
John Dowling | Ex Officer | Profile |
About Globus Medical Management Performance
The success or failure of an entity such as Globus Medical often depends on how effective the management is. Globus Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Globus management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Globus management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.05 | 0.04 | |
Return On Capital Employed | 0.03 | 0.03 | |
Return On Assets | 0.02 | 0.02 | |
Return On Equity | 0.03 | 0.03 |
Please note, the presentation of Globus Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Globus Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Globus Medical's management manipulating its earnings.
Globus Medical Workforce Analysis
Traditionally, organizations such as Globus Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Globus Medical within its industry.Globus Medical Manpower Efficiency
Return on Globus Medical Manpower
Revenue Per Employee | 313.7K | |
Revenue Per Executive | 82.6M | |
Net Income Per Employee | 24.6K | |
Net Income Per Executive | 6.5M | |
Working Capital Per Employee | 304.6K | |
Working Capital Per Executive | 80.2M |
Complementary Tools for Globus Stock analysis
When running Globus Medical's price analysis, check to measure Globus Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Globus Medical is operating at the current time. Most of Globus Medical's value examination focuses on studying past and present price action to predict the probability of Globus Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Globus Medical's price. Additionally, you may evaluate how the addition of Globus Medical to your portfolios can decrease your overall portfolio volatility.
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Money Managers Screen money managers from public funds and ETFs managed around the world |